TRPM4 and prostate carcinoma: The promoter of TRPM4 that is functional in prostate tissues and prostate cancer did not possess clustered binding sites for ERG, AR, TCF4 or Slug but did have multiple binding sites for SMAD transcription factors, suggesting dominant regulation by the TGFβ pathway.